The Carlyle Group Inc. Common Stock (CG)
The Carlyle Group Inc. (CG) is a global investment firm specializing in private equity, real estate, credit, and infrastructure investments. Founded in 1987, it offers financial advisory and asset management services to a diverse range of clients, including institutions and high-net-worth individuals. The firm is known for its extensive investment portfolio across various industries and geographies.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| August 28, 2025 | $0.35 | 2025-08-18 | 2025-08-18 |
| May 27, 2025 | $0.35 | 2025-05-19 | 2025-05-19 |
| February 28, 2025 | $0.35 | 2025-02-21 | 2025-02-21 |
| November 25, 2024 | $0.35 | 2024-11-18 | 2024-11-18 |
| August 26, 2024 | $0.35 | 2024-08-16 | 2024-08-16 |
Dividends Summary
- The Carlyle Group Inc. Common Stock has issued 42 dividend payments over the past 22 years
- The most recent dividend was paid 23 days ago, on August 28, 2025
- The highest dividend payed out to investors during this period was $0.455 per share
- The average dividend paid during this period was $0.37 per share.
Company News
Global investment firm Carlyle announced pricing of $800 million senior notes due in 2035, with the offering expected to close on September 19, 2025, and proceeds to be used for general corporate purposes.
EQT and CPP Investments have agreed to acquire NEOGOV, a HR and compliance software provider for U.S. public sector agencies, from Warburg Pincus and Carlyle, with plans to accelerate growth and expand the company's technological capabilities.
The article explores three dividend stocks with strong financial performance: Toronto-Dominion Bank, Carlyle Group, and Equitable Holdings, highlighting their growth potential and dividend yields.
Blue Owl Capital is set to report its second-quarter 2024 results on Aug 7. The company's earnings and revenue are expected to decline year-over-year, and the Zacks Rank #3 (Hold) stock has underperformed its peers and the broader market year-to-date.
Entities associated with the Carlyle Group have sold over $4.8 million worth of shares in QuidelOrtho Corp, a company specializing in diagnostic substances. The sales were conducted in accordance with a Rule 10b5-1 trading plan, and the entities still hold a significant number of shares in the company.
